Arbutus Biopharma Corp
Arbutus Biopharma Corp
Insider Sentiment (TTM):
Last Purchase:-Last Sale:2025-02-04Shares Purchased (TTM):0Shares Sold (TTM):0
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:138,639,956Shares Outstanding:193,768,641Institutional Ownership Pct.:71.55%
Earnings Market Reaction:
Filing Date:2026-05-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Arbutus Biopharma Corp (ABUS) — SEC Financial Statements & Analysis
Arbutus Biopharma Corp (ABUS) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 24 | 18 | 22 | 37 | 37 | 36 | 32 | 63 | 43 | 26 | 18 | 27 | |||||
Short Term Investments | - | 73 | - | - | - | 86 | - | - | - | 100 | - | - | |||||
Available For Sale Securities Debt Securities Curr… | 72 | - | 71 | 61 | 76 | - | 96 | 79 | 86 | - | 117 | 125 | |||||
Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | |||||
Accounts And Other Receivables Net Current | 179 | - | - | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 2 | 2 | 3 | 4 | 3 | 2 | 3 | 4 | 4 | 4 | 5 | 4 | |||||
Assets Current | 277 | 94 | 97 | 103 | 117 | 127 | 133 | 148 | 136 | 132 | 142 | 159 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | |||||
Long Term Investments | - | 0 | - | - | - | 0 | 3 | 7 | 9 | 6 | 10 | 11 | |||||
Operating Lease Right Of Use Asset | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | |||||
Assets | 277 | 95 | 98 | 103 | 117 | 132 | 140 | 160 | 150 | 144 | 159 | 177 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 4 | 5 | 5 | 5 | 12 | 8 | 8 | 11 | 8 | 10 | 10 | 9 | |||||
Deferred Revenue Current | - | 0 | 0 | 0 | 7 | 8 | 11 | 11 | 12 | 12 | 12 | 15 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |||||
Liabilities Current | 5 | 6 | 5 | 5 | 19 | 16 | 19 | 23 | 20 | 22 | 22 | 25 | |||||
Deferred Revenue Noncurrent | - | 0 | 0 | 0 | 3 | 3 | - | - | - | 0 | 0 | 0 | |||||
Business Combination Contingent Consideration Liab… | 9 | 8 | 11 | 11 | 11 | 10 | 8 | 8 | 8 | 8 | 7 | 7 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
Liabilities | 17 | 18 | 20 | 20 | 38 | 34 | 34 | 38 | 36 | 38 | 39 | 42 | |||||
Statement Of Stockholders… | |||||||||||||||||
Common Stock Value | 1,444 | 1,421 | 1,419 | 1,417 | 1,416 | 1,410 | 1,408 | 1,403 | 1,377 | 1,350 | 1,346 | 1,344 | |||||
Additional Paid In Capital | 74 | 83 | 83 | 83 | 82 | 82 | 81 | 82 | 80 | 81 | 80 | 77 | |||||
Retained Earnings Accumulated Deficit | -1,210 | -1,380 | -1,376 | -1,369 | -1,371 | -1,347 | -1,334 | -1,314 | -1,295 | -1,277 | -1,257 | -1,237 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -49 | -49 | |||||
Stockholders Equity | 260 | 77 | 77 | 83 | 79 | 97 | 107 | 122 | 115 | 106 | 119 | 135 | |||||
Liabilities And Stockholders Equity | 277 | 95 | 98 | 103 | 117 | 132 | 140 | 160 | 150 | 144 | 159 | 177 | |||||
Accumulated Depreciation Depletion And Amortizatio… | 0 | - | 13 | 13 | 13 | - | 13 | 13 | 12 | - | 12 | 11 | |||||
Common Stock Shares Issued | 197 | 193 | 192 | 192 | 191 | 190 | 189 | 189 | 180 | 170 | 168 | 167 | |||||
Shares Outstanding | 197 | 193 | 192 | 192 | 191 | 190 | 189 | 189 | 180 | 170 | 168 | 167 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.39% | 12.99% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 10.13% | 2.53% | 3.48% | 6.92% | 27.09% | 25.65% | -3.07% | 4.61% | -9.43% | 6.79% | -4.07% | -3.62% |
| 2024 | 22.76% | 13.81% | 37.69% | 7.50% | 6.39% | 10.28% | -11.73% | -18.11% | -15.31% | -3.67% | -5.81% | 7.95% |
| 2023 | - | - | - | -1.46% | -6.31% | -15.53% | 9.73% | 35.14% | 28.65% | -3.37% | 2.25% | 23.22% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 54.26 | 15.73 | 18.80 | 20.53 | 6.01 | 8.15 | 7.02 | 6.56 | 6.69 | 5.87 | 6.34 | 6.47 | |||||
| Quick Ratio | 53.92 | 15.47 | 18.25 | 19.74 | 5.86 | 8.01 | 6.84 | 6.36 | 6.47 | 5.68 | 6.11 | 6.32 | |||||
| Working Capital | 271.91M | 88.45M | 92.26M | 98.10M | 97.38M | 111.70M | 113.85M | 125.63M | 115.58M | 109.54M | 119.28M | 134.27M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.07 | 0.24 | 0.26 | 0.24 | 0.48 | 0.35 | 0.31 | 0.31 | 0.31 | 0.36 | 0.33 | 0.31 | |||||
| Interest Coverage TTM | - | - | - | - | -2,431.03 | -978.45 | -681.42 | -495.54 | -262.47 | -170.16 | -110.38 | -68.81 | |||||
| Debt Ratio | 0.06 | 0.19 | 0.21 | 0.20 | 0.32 | 0.26 | 0.24 | 0.23 | 0.24 | 0.27 | 0.25 | 0.24 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.97 | 0.12 | 0.12 | 0.12 | 0.05 | 0.04 | 0.05 | 0.06 | 0.08 | 0.11 | 0.12 | 0.12 | |||||
| Days Sales Outstanding TTM | 2.38 | 49.97 | 31.40 | 33.05 | 94.66 | 123.77 | 102.29 | 79.47 | 67.50 | 31.47 | 32.87 | 35.55 | |||||
| Receivables Turnover TTM | 153.52 | 7.30 | 11.62 | 11.04 | 3.86 | 2.95 | 3.57 | 4.59 | 5.41 | 11.60 | 11.10 | 10.27 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.82 | -0.17 | -0.22 | -0.28 | -0.40 | -0.38 | -0.41 | -0.41 | -0.42 | -0.44 | -0.45 | -0.44 | |||||
| Free Cash Flow Per Share TTM | -0.18 | -0.21 | -0.24 | -0.31 | -0.31 | -0.35 | -0.38 | -0.39 | -0.45 | -0.52 | -0.52 | -0.50 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | - | - | - | 101.67% | 102.35% | 102.53% | 103.26% | 104.70% | |||||
| Operating Profit Margin TTM | 81.72% | -270.96% | -320.44% | -386.51% | -1,290.88% | -1,236.74% | -1,233.06% | -827.46% | -616.46% | -430.53% | -359.33% | -323.65% | |||||
| Net Profit Margin TTM | 83.95% | -237.88% | -289.45% | -351.92% | -1,195.86% | -1,133.04% | -1,137.64% | -766.20% | -572.81% | -401.57% | -339.32% | -309.89% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 2,889.93% | 128.21% | 116.64% | 53.23% | -50.69% | -65.98% | -69.69% | -57.25% | -60.80% | -53.51% | -38.19% | -29.47% | |||||
| Net Income Growth (1Y) | -309.90% | -52.09% | -44.88% | -29.62% | 2.94% | -4.02% | 1.63% | 5.70% | 6.22% | 4.89% | 8.72% | -4.16% | |||||
| EPS Growth (1Y) | -306.58% | -53.58% | -45.68% | -30.91% | -5.20% | -14.18% | -9.92% | -6.66% | -2.24% | -4.61% | -2.00% | -14.15% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 5.43 | -27.51 | -20.59 | -10.91 | -8.69 | -8.68 | -9.49 | -7.54 | -6.09 | -5.70 | -4.51 | -5.24 | |||||
| P/B | 3.35 | 12.04 | 11.25 | 7.13 | 8.41 | 6.23 | 6.81 | 4.75 | 3.95 | 3.91 | 2.85 | 2.84 | |||||
| P/S TTM | 4.55 | 65.44 | 59.61 | 38.39 | 103.95 | 98.35 | 107.93 | 57.75 | 34.89 | 22.87 | 15.29 | 16.23 | |||||
| Market Cap | 871.96M | 921.59M | 870.68M | 591.89M | 665.57M | 606.94M | 727.64M | 581.05M | 453.11M | 414.90M | 340.05M | 381.95M | |||||
| Enterprise Value | 848.25M | 903.59M | 848.27M | 554.48M | 628.49M | 570.61M | 695.79M | 518.26M | 410.01M | 388.62M | 322.52M | 354.75M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -34.36M | -39.64M | -45.36M | -60.28M | -59.03M | -65.03M | -71.92M | -73.00M | -78.92M | -86.94M | -86.78M | -83.74M | |||||
| Net Debt | -23.71M | -18.01M | -22.41M | -37.41M | -37.08M | -36.33M | -31.85M | -62.79M | -43.10M | -26.29M | -17.53M | -27.20M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2025-02-04Sale
Owner: Hastings, David C
Title: Chief Financial Officer
Shares: 22,183
Price/Share: $3.28
Value: $72,760.24
Shares Owned: 159,724
Relationship: Officer
Ownership: Direct
2025-02-04Sale
Owner: Mcelhaugh, Michael J.
Title: Interim President & CEO
Shares: 23,790
Price/Share: $3.28
Value: $78,031.20
Shares Owned: 1,481,003
Relationship: Director,Officer
Ownership: Direct
2025-02-04Sale
Owner: Sims, Karen
Title: Chief Medical Officer
Shares: 19,348
Price/Share: $3.28
Value: $63,461.44
Shares Owned: 106,194
Relationship: Officer
Ownership: Direct
2025-02-04Sale
Owner: Naftzger, J. Christopher
Title: General Counsel and CCO
Shares: 11,333
Price/Share: $3.28
Value: $37,172.24
Shares Owned: 86,244
Relationship: Officer
Ownership: Direct
2024-08-14Sale
Owner: Manchester, Keith S
Title: -
Shares: 8,846
Price/Share: $3.69
Value: $32,641.74
Shares Owned: 46,069
Relationship: Director
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
71.55%
Inst. Shares: 138,639,956
Shares Outstanding: 193,768,641
2025-12-31
63.61%
Inst. Shares: 121,879,122
Shares Outstanding: 191,599,600
2025-09-30
61.53%
Inst. Shares: 118,009,887
Shares Outstanding: 191,778,950
2025-06-30
61.33%
Inst. Shares: 117,469,163
Shares Outstanding: 191,551,282
2025-03-31
58.34%
Inst. Shares: 111,254,583
Shares Outstanding: 190,707,085